ReFlow Medical, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.reflowmedical.com
Clinical Trials
8
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia
- Conditions
- Critical Limb Ischemia
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- ReFlow Medical, Inc.
- Target Recruit Count
- 518
- Registration Number
- NCT06122974
Pilot Study of the Coronary Spur Stent for In-stent Restenosis (DEEPER CORONARY)
- Conditions
- In-stent Restenosis
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- ReFlow Medical, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06117150
- Locations
- 🇳🇿
Auckland City Hospital Te Toka Tumai, Auckland, Grafton, New Zealand
🇳🇿Wellington Hospital | Capital, Coast and Hutt Valley, Wellington, New Zealand
Single-Arm Study Evaluating Use of the CORA Catheters for the Crossing of Coronary Chronic Total Occlusions
- Conditions
- Coronary Occlusion
- First Posted Date
- 2023-05-08
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- ReFlow Medical, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05848232
- Locations
- 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
- Conditions
- Critical Limb IschemiaPeripheral Arterial Disease
- First Posted Date
- 2022-05-03
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- ReFlow Medical, Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT05358353
- Locations
- 🇺🇸
St. Bernards Heart and Vascular, Jonesboro, Arkansas, United States
🇺🇸Arkansas Heart Hospital, Little Rock, Arkansas, United States
🇺🇸University of California, Irvine Health, Orange, California, United States
A Study of the TEmporary Spur StEnt System for the Treatment of Lesions Located in the InfraPoplitEal ARteries Using a LIMUS-base DCB
- Conditions
- Peripheral Arterial DiseaseCritical Limb Ischemia
- First Posted Date
- 2019-11-14
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- ReFlow Medical, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT04162418
- Locations
- 🇦🇹
Univ.-Klinikum LKH Graz, Graz, Austria
- Prev
- 1
- 2
- Next
News
VIVA24: Late-Breaking Trials Highlight Advances in Peripheral Artery Disease Treatment
The PROMISE II trial demonstrates sustained limb salvage and wound healing at two years using the LimFlow System for no-option CLTI patients.